Corrigendum to “Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials” [Lung Cancer 120 (June) (2018) 137–141](S016950021830309X)(10.1016/j.lungcan.2018.03.020)

Hossein Maymani, Kenneth Hess, Roman Groisberg, David S. Hong, Aung Naing, Sarina Piha-Paul, Filip Janku, Siqing Fu, Apostolia M. Tsimberidou, Shubham Pant, Daniel Karp, Shuang Liu, Ming Sun, John Heymach, George Simon, Funda Meric-Bernstam, Vivek Subbiah

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Corrigendum to “Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials” [Lung Cancer 120 (June) (2018) 137–141](S016950021830309X)(10.1016/j.lungcan.2018.03.020)'. Together they form a unique fingerprint.

Medicine & Life Sciences